Shanghai, China Related Funds
| Fund Name | Location |
| Aspen Capital Group | - |
| Barton Capital | - |
| Canadian Solar | Canada, Guelph, Ontario |
| CHET Marketing | Japan, Tokyo |
| Courtin Investment | - |
| Fairum Ventures | - |
| Fastlane Ventures | Cyprus, Limassol |
| Guangxin Zhaofu Investment | China, Hunan, Zhuzhou |
| Homeward Ventures | - |
| J-Tech Capital | Canada, Ontario, Toronto |
| Madison Bay Capital Partners | New York, New York, United States |
| Motion Equity Partners | France, Ile-de-France, Paris |
| Murphy Family Ventures | - |
| Ningbo Huitian Hede Xinxi | China, Ningbo, Zhejiang |
| Pulau Manukan Ventures | - |
| Rugged Ventures | New York, New York, United States |
| Shanghai Xinhushang Shiye Jituan Touzi Gufen Youxian Gongsi | China, Hongkou District |
| Shenzhen Rainbow Venture Capital Holdings | China, Guangdong, Shenzhen |
| Southpaw Asset Management | Connecticut, Greenwich, United States |
| SRS Investment Management | New York, New York, United States |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
EigenCOMM | $154M | 12 Jan 2022 | Shanghai, China | ||
Tingyun | $61M | 07 Sep 2020 | Dongcheng District, Beijing, China | ||
TOT BIOPHARM | $102M | 08 Aug 2018 | China, Jiangsu |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
EigenCOMM | $154M | 12 Jan 2022 | Shanghai, China | ||
Tingyun | $61M | 07 Sep 2020 | Dongcheng District, Beijing, China | ||
TOT BIOPHARM | $102M | 08 Aug 2018 | China, Jiangsu |
